Back to top

Regeneron: Buy Rating Reaffirmed as Analyst Trims Eylea HD Forecasts and Lowers Price Target to $856 on Pipeline-Driven Upside Potential

Analyst Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Regeneron and decreased the price target to $856.00 from $860.00. T...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)